Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family

Abstract Background Germline variants in the DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and PMS2) cause Lynch syndrome, an autosomal dominant hereditary cancer susceptibility syndrome. The risk for endometrial cancer is significantly higher in women with MSH6 pathogenic/likely pathogenic (P/...

Full description

Bibliographic Details
Main Authors: Ciyu Yang, Maksym Misyura, Sarah Kane, Vikas Rai, Alicia Latham, Liying Zhang
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.2104
_version_ 1797903378341167104
author Ciyu Yang
Maksym Misyura
Sarah Kane
Vikas Rai
Alicia Latham
Liying Zhang
author_facet Ciyu Yang
Maksym Misyura
Sarah Kane
Vikas Rai
Alicia Latham
Liying Zhang
author_sort Ciyu Yang
collection DOAJ
description Abstract Background Germline variants in the DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and PMS2) cause Lynch syndrome, an autosomal dominant hereditary cancer susceptibility syndrome. The risk for endometrial cancer is significantly higher in women with MSH6 pathogenic/likely pathogenic (P/LP) variants compared with that for MLH1 or MSH2 variants. Methods The proband was tested via a clinical testing, Memorial Sloan Kettering‐Integrated Mutation Profiling of Actionable Cancer Targets (MSK‐IMPACT). RT‐PCR was performed using patient's blood DNA and cDNA was analyzed by DNA sequencing and a cloning approach. Results We report a 56‐year‐old female with endometrial cancer who carries a germline variant, MSH6 c.4001G > C, located at the last nucleotide of exon 9. While the pathogenicity of this variant was previously unknown, functional studies demonstrated that this variant completely abolished normal splicing and caused exon 9 skipping, which is expected to lead to a prematurely truncated or abnormal protein. Conclusion Our results indicate that this variant likely contributes to cancer predisposition through disruption of normal splicing, and is classified as likely pathogenic.
first_indexed 2024-04-10T09:31:57Z
format Article
id doaj.art-5f5b5db9029c43c68562281eb0dd665e
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-04-10T09:31:57Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-5f5b5db9029c43c68562281eb0dd665e2023-02-18T19:05:42ZengWileyMolecular Genetics & Genomic Medicine2324-92692023-02-01112n/an/a10.1002/mgg3.2104Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome familyCiyu Yang0Maksym Misyura1Sarah Kane2Vikas Rai3Alicia Latham4Liying Zhang5Department of Pathology Memorial Sloan Kettering Cancer Center New York New York USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York New York USADepartment of Medicine Memorial Sloan Kettering Cancer Center New York New York USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York New York USADepartment of Medicine Memorial Sloan Kettering Cancer Center New York New York USADepartment of Pathology Memorial Sloan Kettering Cancer Center New York New York USAAbstract Background Germline variants in the DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and PMS2) cause Lynch syndrome, an autosomal dominant hereditary cancer susceptibility syndrome. The risk for endometrial cancer is significantly higher in women with MSH6 pathogenic/likely pathogenic (P/LP) variants compared with that for MLH1 or MSH2 variants. Methods The proband was tested via a clinical testing, Memorial Sloan Kettering‐Integrated Mutation Profiling of Actionable Cancer Targets (MSK‐IMPACT). RT‐PCR was performed using patient's blood DNA and cDNA was analyzed by DNA sequencing and a cloning approach. Results We report a 56‐year‐old female with endometrial cancer who carries a germline variant, MSH6 c.4001G > C, located at the last nucleotide of exon 9. While the pathogenicity of this variant was previously unknown, functional studies demonstrated that this variant completely abolished normal splicing and caused exon 9 skipping, which is expected to lead to a prematurely truncated or abnormal protein. Conclusion Our results indicate that this variant likely contributes to cancer predisposition through disruption of normal splicing, and is classified as likely pathogenic.https://doi.org/10.1002/mgg3.2104c.4001G > CgermlineLynch syndromeMSH6splice site variant
spellingShingle Ciyu Yang
Maksym Misyura
Sarah Kane
Vikas Rai
Alicia Latham
Liying Zhang
Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family
Molecular Genetics & Genomic Medicine
c.4001G > C
germline
Lynch syndrome
MSH6
splice site variant
title Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family
title_full Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family
title_fullStr Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family
title_full_unstemmed Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family
title_short Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family
title_sort characterization of a germline variant msh6 c 4001g c in a lynch syndrome family
topic c.4001G > C
germline
Lynch syndrome
MSH6
splice site variant
url https://doi.org/10.1002/mgg3.2104
work_keys_str_mv AT ciyuyang characterizationofagermlinevariantmsh6c4001gcinalynchsyndromefamily
AT maksymmisyura characterizationofagermlinevariantmsh6c4001gcinalynchsyndromefamily
AT sarahkane characterizationofagermlinevariantmsh6c4001gcinalynchsyndromefamily
AT vikasrai characterizationofagermlinevariantmsh6c4001gcinalynchsyndromefamily
AT alicialatham characterizationofagermlinevariantmsh6c4001gcinalynchsyndromefamily
AT liyingzhang characterizationofagermlinevariantmsh6c4001gcinalynchsyndromefamily